drug development - search results

The Algae4IBD project is studying the potential of probiotics and algae-derived prebiotics as a treatment for inflammatory bowel disease.

Poppy Lamberton, Professor of Global Health at the University of Glasgow, is leading an interdisciplinary team aiming to identify cost-effective, sustainable interventions for schistosomiasis, a devastating neglected tropical disease.

Professor Curtis R Youngs, the M.E. Ensminger Endowed Chair of International Animal Agriculture at Iowa State University, analyses the flaws of the food system in his fourth part analysis of global food security.

Chelsea Unkel, Ryan Hogans, & Pamela Lein from the University of California, Davis, analyse the fentanyl crisis responsible for increases in drug overdose across the US.

Here, Savage Cabbage Ltd argue for a legitimate Industry Framework when it comes to hemp & CBD

Researchers look at the unfolding tragedy of waste management in informal settlements in South Africa and transferable models for community-based solutions.

Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.

Scientists have proven that African claw frogs can regrow limbs - could humans also have dormant regenerative capabilities?

Reflecting on the recent World Antimicrobial Awareness Week (WAAW 2022), it’s evident that we must continue to raise better awareness and understanding of antimicrobial resistance, which is one of the top 10 global public health threats facing humanity.

Dr. Fredric Schiffer, founder and CEO of MindLight, LLC, looks at treatments for opioid use disorder based on Dual-Brain Psychology and photobiomodulation. Dr. Schiffer is also a part-time assistant professor in psychiatry at Harvard Medical School.

Academic Research Scholar, Prof Wendy M. Purcell, provides an update on COVID-19, communicable disease and immunology.

Sean Lawler, Associate Professor at Brown University pursues an understanding of cancer through the lens of the molecular and cellular ecosystem and natural selection.

Honeywell's Manufacturing Excellence Platform will revolutionise the digital transformation of the life sciences industry.

Professor Jon Crowcroft FRS FREng, co-founder of iKVA, Researcher at Large, at The Alan Turing Institute and Professor of Communication Systems at Cambridge University’s Computer Laboratory, provides his view on Artificial Intelligence in the UK.

Dr Zisis Kozlakidis and Dr Dewi Nur Aisyah examine Hepatitis C virus elimination and weigh up if this has the potential to become a global success story.

Sabine Hölter, Coordinator of the European Brain Research Area cluster PREMOS, calls attention to the translational value of animal models in brain research.

MyBones explores the potential Low-intensity Vibration therapy has as a natural alternative to prevent and combat osteoporosis.

Expert scientists working on endocannabinoid system (ECS) trials explain how CB₂R can be used to treat inflammatory diseases.

Organic chemist with PhD and long standing professional experience in drug discovery and development; Highly skilled and experienced laboratory and project team leader with proven track record reaching advanced stages up to phase 3 clinical trials; Strong background on different target classes, a broad variety of indications and on...

Therapeutic strategies for multiple sclerosis reduce the number of relapses and improve quality of life early in the disease course, nevertheless, neurodegeneration ultimately gives rise to permanent disability.